[ CAS No. 54614-95-8 ] {[proInfo.proName]}

Name: 54614-95-8|tert-Butyl (3-oxobutyl)carbamate|95%
Brand: Ambeed
SKU: A227797
Rating: 95 (29 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 54614-95-8

Structure of 54614-95-8 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 54614-95-8 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 54614-95-8 ]

SDS Specification

Alternatived Products of [ 54614-95-8 ]

Product Details of [ 54614-95-8 ]

CAS No. :	54614-95-8	MDL No. :	MFCD14539579
Formula :	C₉H₁₇NO₃	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	KMENCUFZHDXKNM-UHFFFAOYSA-N
M.W :	187.24	Pubchem ID :	12111481
Synonyms :

Safety of [ 54614-95-8 ]

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P305+P351+P338-P302+P352	UN#:
Hazard Statements:	H315-H319-H335	Packing Group:
GHS Pictogram:

Application In Synthesis of [ 54614-95-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 54614-95-8 ]
Downstream synthetic route of [ 54614-95-8 ]

[ 54614-95-8 ] Synthesis Path-Upstream 1~1

1
[ 54614-95-8 ]
[ 167216-30-0 ]

Reference： [1] Organic Letters, 2009, vol. 11, # 12, p. 2547 - 2550

[ 54614-95-8 ] Synthesis Path-Downstream 1~42

1
[ 123-76-2 ]
[ 75-65-0 ]
[ 54614-95-8 ]

Reference： [1]Tetrahedron,1974,vol. 30,p. 2151 - 2157

2
[ 24424-99-5 ]
[ 92901-20-7 ]
[ 54614-95-8 ]

Reference： [1]Monatshefte fur Chemie,2001,vol. 132,p. 279 - 293
[2]Bioorganic and Medicinal Chemistry Letters,2007,vol. 17,p. 1274 - 1279

3
[ 54614-95-8 ]
[ 105-34-0 ]
methyl (Z)-5-((tert-butoxycarbonyl)-amino)-2-cyano-3-methyl-2-pentenoate [ No CAS ]
methyl (E)-5-((tert-butoxycarbonyl)-amino)-2-cyano-3-methyl-2-pentenoate [ No CAS ]

Reference： [1]Monatshefte fur Chemie,2001,vol. 132,p. 279 - 293

4
[ 917-64-6 ]
[ 142570-56-7 ]
[ 54614-95-8 ]

Reference： [1]Journal of Medicinal Chemistry,2015,vol. 58,p. 4573 - 4580
[2]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

5
[ 867-13-0 ]
[ 54614-95-8 ]
[ 612065-59-5 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

6
[ 54614-95-8 ]
[ 3303-84-2 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2007,vol. 17,p. 1274 - 1279

7
[ 54614-95-8 ]
[ 874942-21-9 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2007,vol. 17,p. 1274 - 1279

8
[ 3303-84-2 ]
[ 54614-95-8 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484
[2]Journal of Medicinal Chemistry,2015,vol. 58,p. 4573 - 4580
[3]Patent: WO2020/154673,2020,A1

9
[ 24424-99-5 ]
[ 54614-95-8 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

10
[ 54614-95-8 ]
[ 612065-61-9 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

11
[ 54614-95-8 ]
[ 612065-60-8 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

12
[ 54614-95-8 ]
(2S,3R)-5-tert-Butoxycarbonylamino-3-hydroxy-3-methyl-2-(toluene-4-sulfonyloxy)-pentanoic acid ethyl ester [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

13
[ 1027977-74-7 ]
[ 54614-95-8 ]

Reference： [1]Journal of Organic Chemistry,2003,vol. 68,p. 7479 - 7484

14
[ 667939-87-9 ]
[ 54614-95-8 ]
7-Methoxy-2, 3-DIMETHYL-6-OXAZOL-5-YL-2-PHENYLETHYNYL-2, 3-DIHYDRO-1 H-QUINAZOLIN-4-ONE [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
5%	In DMF (N,N-dimethyl-formamide); at 140℃; for 0.5h;	A solution of Intermediate 2 (100mg) and tert-butyl 3-oxobutylcarbamic acid (340mg) in DMF [(3ML)] was heated in a sealed tube in a microwave reactor to [140C] for 30 mins. After cooling, the solvent was evaporated under vacuum, and the residue purified by preparative HPLC (Method A) to yield the title compound as a beige solid (9mg, 5%). LCMS 417 [M+H] +, RT 2.96 [MINS.'H] NMR 400MHz (d6-DMSO) 8.30 (1H, s), 7.91 (1H, s), 7.38 (1H, s), 7.15 (1H, s), 6.83 (1H, t), 6.31 (1H, s), 3.90 (3H, s), 3.05-3. 15 (1H, m), 2.85-2. 95 (4H, m), 2.0-2. 1 (1 H, m), 2.7-2. 8 (1 H, m), 1.44 (3H, s), 1.35 (9H, s).

Reference： [1]Patent: WO2004/18462,2004,A1 .Location in patent: Page 58

15
[ 1033064-97-9 ]
[ 54614-95-8 ]

Reference： [1]Chemical Communications,2008,p. 1932 - 1934

16
[ 167216-30-0 ]
[ 54614-95-8 ]

Yield	Reaction Conditions	Operation in experiment
88%	With N-chloro-succinimide; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; tetrabutylammomium bromide; sodium hydrogencarbonate; potassium carbonate; In chloroform; water; at 20℃; for 18h;	C5. (3-oxo-n-butyl)-carbamic acid tert-butyl ester A solution of 5.12 g (1.0 eq) <strong>[167216-30-0]tert-butyl N-(3-hydroxy-n-butyl)carbamate</strong>, 0.87 g (0.1 eq) tetra-n-butylammonium bromide, 0.42 g (0.1 eq) 2,2,6,6-tetramethylpiperidinyloxy (TEMPO), 5.43 g (1.5 eq) N-chlorosuccinimide, 0.65 g (0.17 eq) potassium carbonate and 4.00 g (1.7 eq) sodium hydrogen carbonate in 95 mL warter and 95 mL chloroform is stirred for 18 hours at ambient temperature. The phases are separated and the organic layer is dried over magnesiumsulfate. After evaporation of the solvent the crude product is purified by silica gel flash chromatography (n-hexane/ethylacetate = 100:0 to 50:50) to afford 4.47 g (88%) of the title compound as colorless oil.

Reference： [1]Patent: EP2070932,2009,A1 .Location in patent: Page/Page column 42

17
[ 4248-19-5 ]
[ 78-94-4 ]
[ 54614-95-8 ]

Reference： [1]Organic Letters,2009,vol. 11,p. 2547 - 2550

18
[ 54614-95-8 ]
[ 167216-30-0 ]

Reference： [1]Organic Letters,2009,vol. 11,p. 2547 - 2550

19
[ 54614-95-8 ]
[ 1620483-19-3 ]

Reference： [1]Journal of the American Chemical Society,2014,vol. 136,p. 10777 - 10782
[2]Patent: WO2020/154673,2020,A1

20
[ 934-32-7 ]
[ 54614-95-8 ]
tert-butyl [3-[(1H-benz[d]imidazol-2-yl)amino]butyl]carbamate [ No CAS ]